303 results on '"Horiguchi, Norio"'
Search Results
2. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery
3. Transforming growth factor-α activates pancreatic stellate cells and may be involved in matrix metalloproteinase-1 upregulation
4. Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirin
5. Spontaneous remission of hepatitis B virus reactivation during direct‐acting antiviral agent‐based therapy for chronic hepatitis C
6. Endoscopic treatment for esophageal varices complicated by Isaacs' syndrome involving difficulty with conventional sedation
7. Adolescents with chronic hepatitis C might be good candidates for direct‐acting antiviral therapy
8. # 1439 Three cases of the hepatitis C patients that presented hyperkalemia during daclatasvir and asunaprevir combination therapy
9. # 1018 Hepatic angiosarcoma with dyskeratosis congenita
10. # 1093 Malignant peripheral nerve sheath tumor of the liver
11. # 1011 A case of endoscopic treatment for esophageal varices complicated by Isaacsʼ syndrome involving difficulty with conventional sedation
12. Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma
13. A case of hemorrhagic gastroduodenitis after proton beam radiation for pancreatic cancer with multiple hemorrhagic risk factors: successful treatment with argon plasma coagulation
14. Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis
15. Cell Type–Dependent Pro- and Anti-Inflammatory Role of Signal Transducer and Activator of Transcription 3 in Alcoholic Liver Injury
16. Paracrine Activation of Hepatic CB 1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver
17. HGF ameliorates a high-fat diet-induced fatty liver
18. The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis
19. Hepatocyte growth factor accelerates thrombopoiesis in transgenic mice
20. Interferon treatment for patients with chronic hepatitis C complicated with chronic renal failure receiving hemodialysis
21. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine
22. Response-guided peginterferon-alpha-2b plus ribavirin therapy for chronic hepatitis C patients with genotype 2 and high viral loads
23. Optimal follow-up time to determine the sustained virological response in patients with chronic hepatitis C receiving pegylated-interferon and ribavirin
24. Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10–deficient mice
25. Reply
26. Molecular Mechanisms of Alcoholic Liver Disease: Innate Immunity and Cytokines
27. Transforming growth factor-α attenuates hepatic fibrosis: possible involvement of matrix metalloproteinase-1
28. Constitutive active/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitis
29. Ipragliflozin-induced improvement of liver steatosis in obese mice may involve sirtuin signaling
30. Dissociation Between Liver Inflammation and Hepatocellular Damage Induced by Carbon Tetrachloride in Myeloid Cell–Specific Signal Transducer and Activator of Transcription 3 Gene Knockout Mice
31. Anti-Inflammatory and Anti-Apoptotic Roles of Endothelial Cell STAT3 in Alcoholic Liver Injury
32. Hepatocyte growth factor protects against Fas-mediated liver apoptosis in transgenic mice
33. Transforming growth factor-α accelerates hepatocyte repopulation after hepatocyte transplantation
34. Elevated plasma resistin concentrations in patients with liver cirrhosis
35. ROLE OF STAT 3 IN ALCOHOLIC FATTY LIVER: 243
36. CHRONIC ETHANOL CONSUMPTION INHIBITS HEPATIC NK CELL ACTIVITY BY ATTENUATION OF ACTIVATING SIGNAL AND ACCELERATES MCMV-INDUCED HEPATITIS: 833
37. ANTI-STEATOTIC EFFECT OF STAT3 IN ALCOHOLIC FATTY LIVER DISEASE VIA SUPPRESSION OF SREBP-1: 097
38. STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice
39. Lack of macrophage migration inhibitory factor protects mice against concanavalin A-induced liver injury
40. Role of serum soluble Fas/soluble Fas ligand and TNF-α on response to interferon-α therapy in chronic hepatitis C
41. Iron enhances hepatitis C virus replication in cultured human hepatocytes
42. Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature
43. Mo1463 – Drug Induced Liver Injury Due to Immune Checkpoint Blockades in Japan
44. Su1561 – Long-Term Results of Bariatric Surgery for Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients
45. CCl4-induced acute liver injury in mice is inhibited by hepatocyte growth factor overexpression but stimulated by NK2 overexpression
46. Transforming growth factor α protects against Fas-mediated liver apoptosis in mice
47. Integrative roles of transforming growth factor-α in the cytoprotection mechanisms of gastric mucosal injury
48. Overexpression of hepatocyte growth factor/scatter factor promotes vascularization and granulation tissue formation in vivo
49. Constitutive androstane receptor and pregnane X receptor cooperatively ameliorate DSS-induced colitis
50. Non-invasive prediction of non-alcoholic steatohepatitis in Japanese patients with morbid obesity by artificial intelligence using rule extraction technology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.